Results 121 to 130 of about 319,380 (216)

Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study [PDF]

XE (Ixekizumab) is a monoclonal antibody targeting interleukin-17A (IL17A) which has demonstrated significant efficacy and safety in the management of psoriatic arthritis (PsA) in randomized controlled trials (RCTs).
Antonella Farina, Bernd Raffeiner, Fabio Mascella, Eleonora Celletti, Myriam Di Penta, Dario Camellino, Maddalena Larosa, Francesco Colella Molica, Francesca Serale, Gianluca Smerilli, Rosalba Caccavalle, Eleonora Di Donato, Camilla Mazzanti, Mirco Magnani, Francesco De Lucia, Gerolamo Bianchi, Gianluca Lucchini, Olga Addimanda, Giulio Ferrero, Claudio Angrisani, Emanuela Sabatini, Marino Paroli, Roberta Foti, Elisa Visalli, Natalia Mansueto, Patrizia Del Medico, Aldo Biagio Colella Molica, Rosetta Vitetta, Alberto Lo Gullo, Francesca Ometto, Elena Bravi, Guido Rovera, Dilia Giuggioli, Valeria Nucera, Massimo Reta, Federica Lumetti, Antonio Marchetta, Carlo Salvarani, Vincenzo Bruzzese, Andrea Becciolini, Davide Murgia, Giuditta Adorni, Giorgio Amato, Alessandra Bezzi, Viviana Ravagnani, Alessandro Volpe, Simone Bernardi, Veronica Franchina, Daniele Santilli, Eugenio Arrigoni, Ilaria Platè, Simone Parisi, Alarico Ariani, Ylenia Dal Bosco, Marta Priora, Palma Scolieri, Massimiliano De Simone, Rosario Foti, Gianluca Santoboni, Romina Andracco, Pietro Del Biondo, Francesco Girelli, Cecilia Giampietro, Enrico Fusaro, Gilda Sandri, Maria Chiara Ditto, Aurora Ianniello   +66 more
core   +1 more source

Imaging in psoriatic arthritis: established methods and emerging techniques

Therapeutic Advances in Musculoskeletal Disease
Psoriatic arthritis (PsA) is a heterogeneous, chronic, inflammatory musculoskeletal disease that can lead to peripheral and axial damage and loss of function. A clear difference between PsA and other forms of inflammatory arthritis is the different forms
Yingzhao Jin, Isaac T Cheng, Dongze Wu, Xianfeng Yan, Sze-Lok Lau, Nga Sze Wong, Vivian W Hung, Ling Qin, Ryan Ka Lok Lee, James F Griffith, Cheuk-Chun Szeto, Ho So, Lai-Shan Tam   +12 more
doaj   +1 more source

Study of the Gut Microbiome in Patients with Psoriatic Arthritis

Background: Gut dysbiosis may play a role in immune-mediated diseases, such as psoriasis. There is a growing interest in understanding microbiome influence, with speculations around the importance of an altered gut microbiome linked to the progression to
Gláucio Ricardo Werner Castro, Sueli Carneiro, Gustavo Moreira Amorim   +2 more
core   +1 more source

Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study

Biologics: Targets & Therapy, 2012
Fabrizio Cantini, Laura Niccoli, Emanuele Cassarà, Olga Kaloudi, Carlotta NanniniDivision of Rheumatology, Misericordia e Dolce Hospital of Prato, Prato, ItalyPurpose: The primary purpose of this study was to evaluate the proportion ...
Cantini F, Niccoli L, Cassarà E, Kaloudi O, Nannini C   +4 more
doaj  

Ultrasonographic and power doppler parameters of nails fail to differentiate between onychodystrophy in patients with psoriasis vulgaris or psoriatic arthritis

Advances in Rheumatology
Background Nail involvement is frequent in patients with psoriasis (Pso) and psoriatic arthritis (PsA) and there is a relationship between nail involvement and inflammation of the enthesis.
Anber Ancel Tanaka, Betina Werner, Annelise Correa Bueno Bragatto, Thelma Larocca Skare, Bárbara Stadler   +4 more
doaj   +1 more source

Immune response and cytokine pathways in psoriatic arthritis: A systematic review

The Turkish Journal of Gastroenterology
Objectives: This review aims to focus on the role of innate and adaptive immune system cells and their molecular signaling pathways in the pathophysiology of clinical phenotypes of psoriatic arthritis (PsA).
Gamze Dilek, Mehtap Kalcik Unan, Kemal Nas   +2 more
doaj  

Assessing The Disease Course And Treatment of Psoriatic Arthritis (PSA) In Canada [PDF]

Value in Health, 2017
A MacPherson, S Chiva-Razavi, M Barbeau, J Piercy, S Blackburn, E Sullivan, H Tian, SM Jugl   +7 more
openaire   +1 more source

Outcome measures in psoriatic arthritis

, 2005
Recent advances in biologic therapies have provided hope for patients with psoriatic arthritis (PsA). However, studies have been hampered by the lack of acceptable and validated outcome measures.
Helliwell, Philip S., Taylor, William, Krueger, Gerald, Van Der Heidje, Désirée M. F. M., Kavanaugh, Arthur F., Ritchlin, Christopher T., Gladman, Dafna D., Mease, Philip J., Nash, Peter, Strand, C. Vibeke, Antoni, Christian   +10 more
core  

Trends and Hotspots in Psoriasis-Related Musculoskeletal Research. [PDF]

Orthop Rev (Pavia)
Joseph A, Haddadin S, Viswanath O, Ganti L.   +3 more
europepmc   +1 more source

Quality indicators in psoriatic arthritis

, 2007
Psoriatic arthritis (PsA) is an autoimmune, chronic, systemic inflammatory disorder characterized by the association of arthritis with psoriasis. Patients with PsA may have a heterogeneous and variable clinical course.
Boehncke, Wolf-Henning, Ritchlin, C., Kavanaugh, A.   +2 more
core